AUPH logo

Aurinia Pharmaceuticals (AUPH) EBITDA

annual EBITDA:

$31.73M+$94.78M(+150.32%)
December 31, 2024

Summary

  • As of today (June 1, 2025), AUPH annual EBITDA is $31.73 million, with the most recent change of +$94.78 million (+150.32%) on December 31, 2024.
  • During the last 3 years, AUPH annual EBITDA has risen by +$209.17 million (+117.88%).
  • AUPH annual EBITDA is now at all-time high.

Performance

AUPH EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHincome statement metrics

quarterly EBITDA:

$30.27M+$23.09M(+321.56%)
March 31, 2025

Summary

  • As of today (June 1, 2025), AUPH quarterly EBITDA is $30.27 million, with the most recent change of +$23.09 million (+321.56%) on March 31, 2025.
  • Over the past year, AUPH quarterly EBITDA has increased by +$34.15 million (+880.21%).
  • AUPH quarterly EBITDA is now at all-time high.

Performance

AUPH quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHincome statement metrics

TTM EBITDA:

$65.88M+$34.15M(+107.64%)
March 31, 2025

Summary

  • As of today (June 1, 2025), AUPH TTM EBITDA is $65.88 million, with the most recent change of +$34.15 million (+107.64%) on March 31, 2025.
  • Over the past year, AUPH TTM EBITDA has increased by +$105.03 million (+268.26%).
  • AUPH TTM EBITDA is now at all-time high.

Performance

AUPH TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

AUPH EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+150.3%+880.2%+268.3%
3 y3 years+117.9%+181.7%+140.1%
5 y5 years+135.3%+221.8%+164.2%

AUPH EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+117.9%at high+181.7%at high+140.1%
5 y5-yearat high+117.9%at high+160.4%at high+137.1%
alltimeall timeat high+117.9%at high+160.4%at high+137.1%

AUPH EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$30.27M(+321.6%)
$65.88M(+107.6%)
Dec 2024
$31.73M(-150.3%)
$7.18M(-65.7%)
$31.73M(+622.7%)
Sep 2024
-
$20.91M(+178.1%)
$4.39M(-119.1%)
Jun 2024
-
$7.52M(-293.8%)
-$23.00M(-41.2%)
Mar 2024
-
-$3.88M(-80.8%)
-$39.15M(-31.6%)
Dec 2023
-$63.05M(-39.2%)
-$20.16M(+210.7%)
-$57.22M(-7.8%)
Sep 2023
-
-$6.49M(-24.8%)
-$62.04M(-1.2%)
Jun 2023
-
-$8.63M(-60.7%)
-$62.77M(-29.3%)
Mar 2023
-
-$21.95M(-12.1%)
-$88.81M(-14.5%)
Dec 2022
-$103.65M(-41.6%)
-$24.97M(+245.6%)
-$103.91M(-5.9%)
Sep 2022
-
-$7.23M(-79.2%)
-$110.38M(-27.7%)
Jun 2022
-
-$34.67M(-6.4%)
-$152.74M(-7.1%)
Mar 2022
-
-$37.04M(+17.8%)
-$164.36M(-7.4%)
Dec 2021
-$177.44M(+72.4%)
-$31.45M(-36.6%)
-$177.44M(+15.5%)
Sep 2021
-
-$49.59M(+7.1%)
-$153.64M(+5.2%)
Jun 2021
-
-$46.29M(-7.7%)
-$146.03M(+15.8%)
Mar 2021
-
-$50.13M(+555.9%)
-$126.11M(+25.1%)
Dec 2020
-$102.92M(+14.6%)
-$7.64M(-81.8%)
-$100.83M(-26.3%)
Sep 2020
-
-$41.97M(+59.2%)
-$136.83M(+20.6%)
Jun 2020
-
-$26.37M(+6.1%)
-$113.48M(+10.6%)
Mar 2020
-
-$24.85M(-43.1%)
-$102.60M(+14.3%)
Dec 2019
-$89.77M(+64.4%)
-$43.65M(+134.5%)
-$89.77M(+71.3%)
Sep 2019
-
-$18.61M(+20.2%)
-$52.40M(+1.3%)
Jun 2019
-
-$15.49M(+28.9%)
-$51.72M(+0.4%)
Mar 2019
-
-$12.02M(+91.5%)
-$51.53M(-5.6%)
Dec 2018
-$54.59M(+19.7%)
-$6.28M(-65.0%)
-$54.59M(-9.2%)
Sep 2018
-
-$17.93M(+17.2%)
-$60.10M(+8.1%)
Jun 2018
-
-$15.30M(+1.5%)
-$55.59M(+11.3%)
Mar 2018
-
-$15.08M(+28.0%)
-$49.97M(+9.6%)
Dec 2017
-$45.61M(+113.8%)
-$11.78M(-12.3%)
-$45.61M(+9.9%)
Sep 2017
-
-$13.43M(+38.7%)
-$41.49M(+25.4%)
Jun 2017
-
-$9.68M(-9.7%)
-$33.09M(+19.9%)
Mar 2017
-
-$10.72M(+40.0%)
-$27.60M(+29.4%)
Dec 2016
-$21.34M(-3.1%)
-$7.66M(+52.3%)
-$21.34M(+13.3%)
Sep 2016
-
-$5.03M(+20.1%)
-$18.84M(-4.9%)
Jun 2016
-
-$4.19M(-6.1%)
-$19.80M(-7.1%)
Mar 2016
-
-$4.46M(-13.6%)
-$21.30M(-3.3%)
Dec 2015
-$22.02M(+23.2%)
-$5.16M(-13.9%)
-$22.02M(-10.3%)
Sep 2015
-
-$5.99M(+5.4%)
-$24.56M(+78.6%)
Jun 2015
-
-$5.69M(+9.9%)
-$13.75M(-26.6%)
Mar 2015
-
-$5.18M(-32.7%)
-$18.73M(+4.5%)
Dec 2014
-$17.87M(+217.0%)
-$7.70M(-259.9%)
-$17.93M(+58.5%)
Sep 2014
-
$4.81M(-145.1%)
-$11.31M(-40.9%)
Jun 2014
-
-$10.66M(+143.7%)
-$19.13M(+105.0%)
Mar 2014
-
-$4.38M(+306.3%)
-$9.34M(+65.6%)
Dec 2013
-$5.64M(-36.1%)
-$1.08M(-64.3%)
-$5.64M(-40.7%)
Sep 2013
-
-$3.02M(+248.3%)
-$9.50M(+19.2%)
Jun 2013
-
-$866.00K(+27.5%)
-$7.97M(-13.3%)
Mar 2013
-
-$679.00K(-86.3%)
-$9.20M(+5.0%)
Dec 2012
-$8.83M(+510.8%)
-$4.94M(+232.5%)
-$8.76M(+475.1%)
Sep 2012
-
-$1.49M(-29.0%)
-$1.52M(+66.6%)
Jun 2012
-
-$2.09M(+773.6%)
-$914.20K(-114.5%)
Mar 2012
-
-$239.50K(-110.4%)
$6.31M(+26.2%)
DateAnnualQuarterlyTTM
Dec 2011
-$1.45M(-65.8%)
$2.29M(-361.6%)
$5.00M(+832.0%)
Sep 2011
-
-$876.90K(-117.1%)
$536.10K(+110.9%)
Jun 2011
-
$5.13M(-431.0%)
$254.20K(-105.0%)
Mar 2011
-
-$1.55M(-28.5%)
-$5.07M(+20.3%)
Dec 2010
-$4.23M(-32.8%)
-$2.17M(+86.9%)
-$4.22M(+240.2%)
Sep 2010
-
-$1.16M(+478.8%)
-$1.24M(-26.0%)
Jun 2010
-
-$200.20K(-71.1%)
-$1.67M(-55.5%)
Mar 2010
-
-$691.60K(-185.3%)
-$3.76M(-32.3%)
Dec 2009
-$6.28M(-55.8%)
$811.10K(-150.9%)
-$5.56M(-23.5%)
Sep 2009
-
-$1.59M(-30.3%)
-$7.27M(-20.4%)
Jun 2009
-
-$2.29M(-8.1%)
-$9.13M(-24.3%)
Mar 2009
-
-$2.49M(+176.8%)
-$12.06M(-16.3%)
Dec 2008
-$14.22M(-58.3%)
-$898.40K(-74.0%)
-$14.42M(-33.2%)
Sep 2008
-
-$3.46M(-33.8%)
-$21.60M(-16.7%)
Jun 2008
-
-$5.22M(+7.8%)
-$25.92M(-13.9%)
Mar 2008
-
-$4.84M(-40.0%)
-$30.10M(-5.8%)
Dec 2007
-$34.12M(+51.0%)
-$8.08M(+3.8%)
-$31.95M(+7.6%)
Sep 2007
-
-$7.78M(-17.3%)
-$29.69M(+5.6%)
Jun 2007
-
-$9.40M(+40.3%)
-$28.11M(+14.6%)
Mar 2007
-
-$6.70M(+15.4%)
-$24.52M(+9.8%)
Dec 2006
-$22.60M(-19.7%)
-$5.81M(-6.3%)
-$22.33M(-6.7%)
Sep 2006
-
-$6.20M(+6.7%)
-$23.94M(-1.1%)
Jun 2006
-
-$5.81M(+28.6%)
-$24.20M(-3.1%)
Mar 2006
-
-$4.52M(-39.0%)
-$24.97M(-8.8%)
Dec 2005
-$28.15M(+35.1%)
-$7.41M(+14.7%)
-$27.39M(-2.0%)
Sep 2005
-
-$6.46M(-1.8%)
-$27.95M(+0.9%)
Jun 2005
-
-$6.58M(-5.1%)
-$27.69M(+13.5%)
Mar 2005
-
-$6.94M(-13.0%)
-$24.41M(+19.1%)
Dec 2004
-$20.83M(+111.9%)
-$7.97M(+28.5%)
-$20.50M(+18.3%)
Sep 2004
-
-$6.20M(+88.4%)
-$17.32M(+16.0%)
Jun 2004
-
-$3.29M(+8.8%)
-$14.94M(+113.1%)
Mar 2004
-
-$3.03M(-36.9%)
-$7.01M(+0.6%)
Dec 2003
-$9.83M(+1040.3%)
-$4.79M(+25.5%)
-$6.97M(+40.3%)
Sep 2003
-
-$3.82M(-182.5%)
-$4.97M(-803.0%)
Jun 2003
-
$4.63M(-255.1%)
$706.50K(-148.6%)
Mar 2003
-
-$2.99M(+7.0%)
-$1.45M(+97.4%)
Dec 2002
-$862.00K(-88.0%)
-$2.79M(-250.8%)
-$736.90K(-135.9%)
Sep 2002
-
$1.85M(-25.1%)
$2.06M(-197.5%)
Jun 2002
-
$2.47M(-209.0%)
-$2.11M(-72.8%)
Mar 2002
-
-$2.27M(-1.8%)
-$7.76M(-24.2%)
Dec 2001
-$7.20M(+13.7%)
-
-
Aug 2001
-
-$2.31M(-27.4%)
-$10.23M(+9.5%)
May 2001
-
-$3.18M(+42.3%)
-$9.35M(+19.3%)
Feb 2001
-
-$2.24M(-10.7%)
-$7.84M(+23.2%)
Nov 2000
-$6.33M(+482.5%)
-$2.50M(+75.6%)
-$6.36M(+44.3%)
Aug 2000
-
-$1.43M(-14.5%)
-$4.40M(+47.9%)
May 2000
-
-$1.67M(+120.1%)
-$2.98M(+73.7%)
Feb 2000
-
-$758.10K(+37.5%)
-$1.71M(+57.4%)
Nov 1999
-$1.09M(-44.4%)
-$551.30K(<-9900.0%)
-$1.09M(+102.5%)
Aug 1999
-
$0.00(-100.0%)
-$538.00K(0.0%)
May 1999
-
-$405.40K(+205.7%)
-$538.00K(+305.7%)
Feb 1999
-
-$132.60K
-$132.60K
Nov 1998
-$1.95M
-
-

FAQ

  • What is Aurinia Pharmaceuticals annual EBITDA?
  • What is the all time high annual EBITDA for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals annual EBITDA year-on-year change?
  • What is Aurinia Pharmaceuticals quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals quarterly EBITDA year-on-year change?
  • What is Aurinia Pharmaceuticals TTM EBITDA?
  • What is the all time high TTM EBITDA for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals TTM EBITDA year-on-year change?

What is Aurinia Pharmaceuticals annual EBITDA?

The current annual EBITDA of AUPH is $31.73M

What is the all time high annual EBITDA for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high annual EBITDA is $31.73M

What is Aurinia Pharmaceuticals annual EBITDA year-on-year change?

Over the past year, AUPH annual EBITDA has changed by +$94.78M (+150.32%)

What is Aurinia Pharmaceuticals quarterly EBITDA?

The current quarterly EBITDA of AUPH is $30.27M

What is the all time high quarterly EBITDA for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high quarterly EBITDA is $30.27M

What is Aurinia Pharmaceuticals quarterly EBITDA year-on-year change?

Over the past year, AUPH quarterly EBITDA has changed by +$34.15M (+880.21%)

What is Aurinia Pharmaceuticals TTM EBITDA?

The current TTM EBITDA of AUPH is $65.88M

What is the all time high TTM EBITDA for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high TTM EBITDA is $65.88M

What is Aurinia Pharmaceuticals TTM EBITDA year-on-year change?

Over the past year, AUPH TTM EBITDA has changed by +$105.03M (+268.26%)
On this page